Booster Therapeutics is a startup, 1 tracked investor.
Booster Therapeutics is a startup founded in 2024. Brouky records 1 investor associated with the company.
Booster Therapeutics is developing a new class of small-molecule proteasome activator medicines designed to boost 20S proteasome activity and restore cellular protein homeostasis, initially focusing on neurodegenerative diseases. The company uses a structure-based DGRADX™ platform combining high-throughput screening, X-ray crystallography, and computational tools to build a pipeline of activator compounds.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.